Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01879085
Title Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hussein Tawbi
Indications

sarcoma

Therapies

Gemcitabine

Docetaxel

Pegfilgrastim

Vorinostat

Age Groups: adult
Covered Countries USA


No variant requirements are available.